Thomas Ryckmans

1.3k total citations · 1 hit paper
29 papers, 877 citations indexed

About

Thomas Ryckmans is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Thomas Ryckmans has authored 29 papers receiving a total of 877 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Organic Chemistry and 9 papers in Cellular and Molecular Neuroscience. Recurrent topics in Thomas Ryckmans's work include Pharmacological Receptor Mechanisms and Effects (6 papers), Receptor Mechanisms and Signaling (6 papers) and Neuropeptides and Animal Physiology (6 papers). Thomas Ryckmans is often cited by papers focused on Pharmacological Receptor Mechanisms and Effects (6 papers), Receptor Mechanisms and Signaling (6 papers) and Neuropeptides and Animal Physiology (6 papers). Thomas Ryckmans collaborates with scholars based in United Kingdom, United States and Belgium. Thomas Ryckmans's co-authors include Dafydd R. Owen, Tim Young, Lisa R. Thompson, Martin P. Edwards, Nicolas H. Thomä, Pablo Gaínza, Vladimiras Oleinikovas, Bernhard Fasching, Stefanie Wagner and Katharina Rox and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and The Annual Review of Pharmacology and Toxicology.

In The Last Decade

Thomas Ryckmans

28 papers receiving 855 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

From Thalidomide to Rational Molecular Glue Design for Targeted Protein Degradation

2023 89 citations Vladimiras Oleinikovas, Pablo Gaínza et al. The Annual Review of Pharmacology and Toxicology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Ryckmans United Kingdom	15	499	305	104	102	77	29	877
John K. Walker United States	20	483 1.0×	193 0.6×	71 0.7×	66 0.6×	123 1.6×	49	1.1k
Thomas H. Hudson United States	20	466 0.9×	200 0.7×	72 0.7×	121 1.2×	76 1.0×	23	1.1k
Simona Musella Italy	18	402 0.8×	388 1.3×	89 0.9×	44 0.4×	95 1.2×	43	921
Chun‐Chen Chen Taiwan	12	386 0.8×	190 0.6×	170 1.6×	27 0.3×	84 1.1×	28	908
Mercedes Martín‐Martínez Spain	21	723 1.4×	374 1.2×	28 0.3×	171 1.7×	68 0.9×	70	1.1k
Minos–Timotheos Matsoukas Greece	19	775 1.6×	208 0.7×	231 2.2×	134 1.3×	79 1.0×	64	1.3k
Joong Myung Cho South Korea	19	930 1.9×	180 0.6×	95 0.9×	60 0.6×	193 2.5×	36	1.3k
Ying‐Duo Gao United States	20	779 1.6×	133 0.4×	110 1.1×	267 2.6×	194 2.5×	27	1.3k
Maryam Hamzeh‐Mivehroud Iran	18	511 1.0×	232 0.8×	179 1.7×	19 0.2×	71 0.9×	74	956
Vijayakumar Gosu South Korea	12	512 1.0×	121 0.4×	314 3.0×	22 0.2×	79 1.0×	25	961

Countries citing papers authored by Thomas Ryckmans

Since Specialization

Citations

This map shows the geographic impact of Thomas Ryckmans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Ryckmans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Ryckmans more than expected).

Fields of papers citing papers by Thomas Ryckmans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Ryckmans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Ryckmans. The network helps show where Thomas Ryckmans may publish in the future.

Co-authorship network of co-authors of Thomas Ryckmans

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Ryckmans. A scholar is included among the top collaborators of Thomas Ryckmans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Ryckmans. Thomas Ryckmans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Oleinikovas, Vladimiras, Pablo Gaínza, Thomas Ryckmans, Bernhard Fasching, & Nicolas H. Thomä. (2023). From Thalidomide to Rational Molecular Glue Design for Targeted Protein Degradation. The Annual Review of Pharmacology and Toxicology. 64(1). 291–312. 89 indexed citations breakdown →

Sommer, Roman, Katharina Rox, Stefanie Wagner, et al.. (2019). Anti-biofilm Agents against Pseudomonas aeruginosa: A Structure–Activity Relationship Study of C-Glycosidic LecB Inhibitors. Journal of Medicinal Chemistry. 62(20). 9201–9216. 59 indexed citations

Molin, Michael Dal, et al.. (2019). Identification of novel scaffolds targeting Mycobacterium tuberculosis. Journal of Molecular Medicine. 97(11). 1601–1613. 21 indexed citations

Kilty, Iain, Andrew Bell, David G. Brown, et al.. (2013). TAK1 Inhibition in the DFG‐Out Conformation. Chemical Biology & Drug Design. 82(5). 500–505. 17 indexed citations

Wijeyesekera, Anisha, Philip A. Clarke, Magda Bictash, et al.. (2011). Quantitative UPLC-MS/MS analysis of the gut microbial co-metabolites phenylacetylglutamine, 4-cresyl sulphate and hippurate in human urine: INTERMAP Study. Analytical Methods. 4(1). 65–72. 28 indexed citations

Ryckmans, Thomas, Aisah A. Aubdool, Jennifer V. Bodkin, et al.. (2011). Design and pharmacological evaluation of PF-4840154, a non-electrophilic reference agonist of the TrpA1 channel. Bioorganic & Medicinal Chemistry Letters. 21(16). 4857–4859. 35 indexed citations

Johnson, Patrick S., Thomas Ryckmans, Justin S. Bryans, et al.. (2011). Discovery of PF-184563, a potent and selective V1a antagonist for the treatment of dysmenorrhoea. The influence of compound flexibility on microsomal stability. Bioorganic & Medicinal Chemistry Letters. 21(19). 5684–5687. 13 indexed citations

Nakagawa, Shoko, et al.. (2011). Application of Barluenga Boronic Coupling (BBC) to the Parallel Synthesis of Drug‐like and Drug Fragment‐like Molecules. ChemMedChem. 7(2). 233–236. 34 indexed citations

Ryckmans, Thomas. (2010). Modulation of the vasopressin system for the treatment of CNS diseases.. PubMed. 13(5). 538–47. 11 indexed citations

10.

Fish, Paul V., Florian Wakenhut, Thomas Ryckmans, & Alan Stobie. (2009). Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template. Bioorganic & Medicinal Chemistry Letters. 19(16). 4579–4583. 3 indexed citations

11.

Owen, Dafydd R., Ross A. Kinloch, Graham N. Maw, et al.. (2009). 2,4-Diaminopyridine δ-opioid receptor agonists and their associated hERG pharmacology. Bioorganic & Medicinal Chemistry Letters. 19(6). 1702–1706. 9 indexed citations

12.

Fish, Paul V., Kimberly S. Para, Thomas Ryckmans, et al.. (2008). Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition. Bioorganic & Medicinal Chemistry Letters. 18(8). 2562–2566. 26 indexed citations

13.

Fish, Paul V., Nancy S. Barta, David Gray, et al.. (2008). Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity. Bioorganic & Medicinal Chemistry Letters. 18(15). 4355–4359. 11 indexed citations

14.

Fish, Paul V., Thomas Ryckmans, Alan Stobie, & Florian Wakenhut. (2008). [4-(Phenoxy)pyridin-3-yl]methylamines: A new class of selective noradrenaline reuptake inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(6). 1795–1798. 9 indexed citations

15.

Génicot, Christophe, B. Christophe, Philippe Collart, et al.. (2003). Discovery of orally bioavailable NK1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 13(3). 437–442. 6 indexed citations

16.

Ryckmans, Thomas, Olivier Berton, R. Grimée, et al.. (2003). Dual NK₁ Antagonists—Serotonin Reuptake Inhibitors as Potential Antidepressants. Part 2. SAR and Activity of Benzyloxyphenethyl Piperazine Derivatives.. ChemInform. 34(8). 1 indexed citations

17.

Ryckmans, Thomas, Olivier Berton, R. Grimée, et al.. (2002). Dual NK1 antagonists—serotonin reuptake inhibitors as potential antidepressants. Part 2: SAR and activity of benzyloxyphenethyl piperazine derivatives. Bioorganic & Medicinal Chemistry Letters. 12(21). 3195–3198. 28 indexed citations

18.

Ryckmans, Thomas, Olivier Berton, Christophe Génicot, et al.. (2002). First dual NK1 antagonists–serotonin reuptake inhibitors: synthesis and SAR of a new class of potential antidepressants. Bioorganic & Medicinal Chemistry Letters. 12(2). 261–264. 52 indexed citations

19.

Ryckmans, Thomas, et al.. (1997). The methylation of N-cyano N-methyl hydrazones: A new access to 2-aminoimidazoles through an in situ 1,3,4-triaza cope rearrangement. DIAL (Catholic University of Leuven). 106(9). 553–557. 1 indexed citations

20.

Ryckmans, Thomas, et al.. (1992). Benzimidazolo-diazepines from 1,3-dienes and arenediazocyanides through a 1,3,4-tri-aza-Cope rerrangement.. Tetrahedron. 48(25). 5249–5258. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact